Amgen (AMGN) downgraded to Equal-Weight from Overweight at Morgan Stanley; target $251
Johnson & Johnson (JNJ) downgraded to Equal-Weight from Overweight at Morgan Stanley; target $187
Merck (MRK) downgraded to Equal-Weight from Overweight at Morgan Stanley; target $85